Dermal dendrocyte ballooning

American Journal of Clinical Dermatology

Volumn 7, Issue 6, 2006, Pages 391-392

  Quatresooz, Pascale ^a   Piérard, Gérald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; METHOTREXATE; MITOXANTRONE; VINCRISTINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL EXAMINATION; DENDRITIC CELL; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; HISTOPATHOLOGY; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MICROSCOPY; PANCYTOPENIA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CELL; TREATMENT DURATION; ACUTE LYMPHOCYTIC LEUKEMIA; BLOOD; KERATINOCYTE; PATHOLOGY; SKIN;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DENDRITIC CELLS; DRUG ERUPTIONS; HUMANS; KERATINOCYTES; LEUKEMIA, LYMPHOCYTIC, ACUTE; METHOTREXATE; SKIN;

EID: 34347273075     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200607060-00009     Document Type: Article

References (17)

1. Headington JT. The dermal dendrocyte. In: Callen JP, Dahl MV, Golitz LE, editors. Advances in dermatology. Chicago (IL): Year Book Medical Publishers, 1986: 159-71
2. Cerio R, Griffiths CEM, Cooper KD, et al. Characterization of factor XIIIa-positive dermal dendritic cells in normal and inflamed skin. Br J Dermatol 1989; 121: 421-31
3. Arrese J, Piérard GE. Factor XIIIa positive dendrocytes and the dermal microvascular unit. Dermatologica 1990; 180: 51-3
4. Headington JT, Cerio R. Dendritic cells and the dermis. Am J Dermatopathol 1990; 12: 217-20
5. Nestle FO, Zheng X, Thompson C, et al. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J Immunol 1993; 151: 6535-45
6. Nestle FO, Nickoloff BJ. A fresh morphological and functional look at dermal dendritic cells. J Cutan Pathol 1995; 22: 385-93
7. Quatresooz P, Piérard GE. Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clin Exp Dermatol 2003; 28: S27-9
8. Paquet P, Nikkels A, Arrese JE, et al. Macrophages and tumor necrosis factor-alpha in toxic epidermal necrolysis. Arch Dermatol 1994; 130: 605-8
9. Paquet P, Piérard GE. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol 1997; 19: 127-32
10. Hermanns-Lê T, Parquet P, Piérard-Franchimont C, et al. Regulatory function of factor XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus reaction: a hypothesis. Dermatology 1999; 198: 184-6
11. Paquet P, Arrese JE, Beguin Y, et al. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction. In: Cerio R, editor. Current topics in pathology. Vol. 94. Dermatopathology. Berlin: Springer Verlag, 2001: 65-78
12. Paquet P, Quatresooz P, Piérard GE. Factor XIIIa-positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyell's syndrome): paradoxical activation in the skin and rarefaction in lymph nodes. Dermatology 2003; 206: 374-8
13. Franchimont C, Piérard GE. Cutaneous pathobiology mediated by chemotherapy. J Cutan Pathol 1980; 7: 387-93
14. Yokel BK, Friedman KJ, Farmer ER, et al. Cutaneous pathology following etoposide therapy. J Cutan Pathol 1987; 14: 326-30
15. Monteiro MR, Murphy EE, Galaria NA, et al. Cytological alterations in dermal dendrocytes in vitro: evidence for transformation to a non-dendritic phenotype. Br J Dermatol 2000; 143: 84-90
16. Hermanns-Lê T, Piérard GE. Factor XIIIa-positive dendrocyte rarefaction in Ehlers-Danlos syndrome, classic type. Am J Dermatopathol 2001; 23: 427-30
17. Quatresooz P, Hermanns-Lê T, Ciccarelli A, et al. Tensegrity and type I dermal dendrocytes in acromegaly. Eur J Clin Invest 2005; 35: 133-9